.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Pancreatic cancer management is evolving rapidly through biotechnology. A promising frontier involves siRNA pancreatic cancer therapy, which uses small ribonucleotides to silence disease-causing genes. Consequently, these molecules can target specific DNA sequences and reduce their expression levels. Since changes in gene expression drive pancreatic cancer, this mechanism provides a powerful tool for intervention.
Silencing critical genes like K-Ras and GJB4 effectively blocks tumor development. Furthermore, siRNAs can improve the efficacy of standard chemotherapeutic drugs. Drugs such as gemcitabine and paclitaxel often face resistance. However, researchers have found that siRNA can reduce drug-resistance-related genes. Therefore, the combination of chemical agents and immunological agents may significantly improve patient survival. Additionally, innovative delivery systems are essential to protect siRNAs from degradation in the bloodstream.
In addition to chemotherapy, siRNAs enhance the effectiveness of immunotherapy. They can modulate the tumor microenvironment to allow immune cells to attack cancer more effectively. Moreover, recent clinical trials indicate that extended-release implants delivering anti-KRAS siRNAs show promising survival trends. These advancements suggest a shift toward more personalized and potent cancer care strategies. Physicians should monitor these developments closely as they transition into clinical practice.
siRNA molecules target and silence genes responsible for drug resistance. This makes cancer cells more susceptible to chemotherapeutic agents like doxorubicin and gemcitabine, thereby increasing treatment efficacy.
Key targets include the K-Ras, GJB4, and SIX4 genes. Silencing these specific genetic sequences can block or even reverse the progression of pancreatic cancer cells.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or professional services. Always seek the advice of your physician or other qualified health provider regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
siRNA therapy combined with chemotherapy offers a novel approach to silence genes like K-Ras, potentially improving pancreatic cancer treatment outcomes....
last month
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
